FDA Approves Abbott Xience DES For Short Dual-Antiplatelet Course

 
• By Reed Miller
  
Abbott's Xience Skypoint Everolimus-Eluting Stent
Abbott's Xience Skypoint Everolimus-Eluting Stent • Source: Abbott

More from Approvals

More from Policy & Regulation